241 related articles for article (PubMed ID: 21214488)
1. Physicochemical properties of lipid nanoparticles: effect of lipid and surfactant composition.
Martins S; Tho I; Ferreira DC; Souto EB; Brandl M
Drug Dev Ind Pharm; 2011 Jul; 37(7):815-24. PubMed ID: 21214488
[TBL] [Abstract][Full Text] [Related]
2. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.
Martins S; Tho I; Souto E; Ferreira D; Brandl M
Eur J Pharm Sci; 2012 Apr; 45(5):613-23. PubMed ID: 22245538
[TBL] [Abstract][Full Text] [Related]
3. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
4. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
Teeranachaideekul V; Müller RH; Junyaprasert VB
Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
[TBL] [Abstract][Full Text] [Related]
6. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2004 Apr; 59(4):331-2. PubMed ID: 15125588
[TBL] [Abstract][Full Text] [Related]
7. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.
Pereira I; Zielińska A; Ferreira NR; Silva AM; Souto EB
Int J Pharm; 2018 Oct; 549(1-2):261-270. PubMed ID: 30075252
[TBL] [Abstract][Full Text] [Related]
8. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
9. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
[TBL] [Abstract][Full Text] [Related]
10. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
11. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
12. A Quality by design (QbD) approach on starch-based nanocapsules: A promising platform for topical drug delivery.
Marto J; Gouveia LF; Gonçalves LM; Gaspar DP; Pinto P; Carvalho FA; Oliveira E; Ribeiro HM; Almeida AJ
Colloids Surf B Biointerfaces; 2016 Jul; 143():177-185. PubMed ID: 27003468
[TBL] [Abstract][Full Text] [Related]
13. Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles.
Kuntsche J; Bunjes H
Eur J Pharm Biopharm; 2007 Nov; 67(3):612-20. PubMed ID: 17574399
[TBL] [Abstract][Full Text] [Related]
14. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method.
Montenegro L; Sarpietro MG; Ottimo S; Puglisi G; Castelli F
Int J Pharm; 2011 Aug; 415(1-2):301-6. PubMed ID: 21679757
[TBL] [Abstract][Full Text] [Related]
15. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system.
Rostamkalaei SS; Akbari J; Saeedi M; Morteza-Semnani K; Nokhodchi A
Colloids Surf B Biointerfaces; 2019 Mar; 175():150-157. PubMed ID: 30530000
[TBL] [Abstract][Full Text] [Related]
16. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
17. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants.
Keck CM; Kovačević A; Müller RH; Savić S; Vuleta G; Milić J
Int J Pharm; 2014 Oct; 474(1-2):33-41. PubMed ID: 25108048
[TBL] [Abstract][Full Text] [Related]
18. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C
Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112
[TBL] [Abstract][Full Text] [Related]
20. Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and
El-Gizawy SA; El-Maghraby GM; Hedaya AA
Pharm Dev Technol; 2019 Dec; 24(10):1287-1298. PubMed ID: 31507232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]